Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 30.57M P/E - EPS this Y 43.50% Ern Qtrly Grth -
Income -81.41M Forward P/E -0.78 EPS next Y 12.90% 50D Avg Chg -46.00%
Sales - PEG 0.53 EPS past 5Y - 200D Avg Chg -51.00%
Dividend N/A Price/Book 1.08 EPS next 5Y -2.49% 52W High Chg -86.00%
Recommedations 1.70 Quick Ratio 5.63 Shares Outstanding 25.60M 52W Low Chg 13.00%
Insider Own 1.98% ROA -75.03% Shares Float 24.77M Beta 0.59
Inst Own 20.39% ROE -136.82% Shares Shorted/Prior 1.14M/1.17M Price 2.56
Gross Margin - Profit Margin - Avg. Volume 227,779 Target Price 11.75
Oper. Margin - Earnings Date May 13 Volume 573,327 Change 0.79%
About Leap Therapeutics, Inc.

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase II clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with NovaRock, Adimab, and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Leap Therapeutics, Inc. News
04/11/24 Leap Therapeutics Announces $40 Million Private Placement
08:35 AM Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
03/18/24 Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
01/16/24 Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
01/03/24 Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
01/02/24 Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
12/11/23 Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
11/21/23 Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
11/13/23 Leap Therapeutics Reports Third Quarter 2023 Financial Results
10/24/23 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
10/03/23 These 2 “Strong Buy” Penny Stocks Could Gain Over 500%, Says Baird
09/05/23 Leap Therapeutics to Participate at Upcoming Investor Conferences
08/14/23 Leap Therapeutics Reports Second Quarter 2023 Financial Results
08/13/23 10 Most Promising Penny Stocks According to Analysts
07/12/23 Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients
11:30 AM Leap Therapeutics Announces Reverse Stock Split
06/04/23 10 Hot Penny Stocks To Buy
05/25/23 Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting
05/15/23 Leap Therapeutics Reports First Quarter 2023 Financial Results
LPTX Chatroom

User Image boilerrm04 Posted - 4 hours ago

$lptx i do remember one thing from The $tril days. They announced 6 new studies June 2020 when we were all hoping for buyout. Stock sank from $20 to $4.89. $pfe bought them out 2 months later in august for $18.44 so anything is possible.

User Image THE_ORJINAL Posted - 9 hours ago

$LPTX super interesting... Gilead in

User Image WesCoastAL Posted - 10 hours ago

$NKGN Leap Therapeutics $LPTX ...

User Image WesCoastAL Posted - 10 hours ago

$LPTX

User Image mlasare Posted - 12 hours ago

$LPTX

User Image kamikaze_andy Posted - 12 hours ago

$LPTX come back to me at $1.75 and twist my rubber arm

User Image Walter100 Posted - 12 hours ago

$LPTX I think it’ll settle around 2.00 . That’s the fair price reflecting latest dilution.

User Image jgodski Posted - 16 hours ago

$ZPTA Looks like Lincoln Park Capital Fund, LLC, or Lincoln Park played the same role for $LPTX in their filing from 2019, language is very similar. Again, what is this relationship for, and did Leap Therapeutics benefit, and how? How did it impact the share price? https://investors.leaptx.com/node/7566/html

User Image THE_ORJINAL Posted - 1 day ago

$LPTX Latest deck published. Seems like timelines got pushed back a bit?

User Image Apr4609 Posted - 2 days ago

$LPTX You guys should consider brphf (galaxy digital) It’s like investing in J.P. Morgan for crypto The halving event is tomorrow and last time that happened btc went up 6x in the following 12 months Galaxy is 8.5$ Could easily be 20-50$ in 12 months The key is to not get to greedy and cash out before the music stops

User Image Roberto121 Posted - 2 days ago

$LPTX I just want to understand one thing I know they raised money 40 million but why are ppl saying our stock price will change ? Why would it change I’m confused can someone explain thank you

User Image Walter100 Posted - 2 days ago

$LPTX I pity those who invested early in the highs before Beigene walked out. I feel the company let them down. This is like an iceberg that finally became an ice cube.

User Image MurrayK Posted - 3 days ago

$LPTX so who are the most likely candidates to be running the daily algo to pull PPS down?

User Image BA777 Posted - 5 days ago

$LPTX What do the chart pros think??

User Image TraderMark71 Posted - 6 days ago

@TomMac64 Not completely true when it comes to these types of stocks. Why are you even invested in this if you have no faith? BTW I have 2850 shares. Why are you arguing with me about this when we are on the same side? I am 2 seconds from blocking you. You are one of the main people I aimed my original comment at about complaining all the time. $ESPR $LPTX $LXRX

User Image TraderMark71 Posted - 6 days ago

@TomMac64 Yes they have a drug for sale, but how many companies stop at one drug? They are also developing new therapies at the same time. This is where a large portion of cash is going to. It is not cheap. I am not bearish on this, I am a shareholder as well and hope the best for them. I am just shedding light on why SP fluctuates sometimes especially when our leaders get involved and F with the market as a whole. If you believe in the company as I do, all I am asking is for everyone to stop whining every time it goes down a little bit. Read my post please... $LPTX $ESPR $LXRX

User Image TomMac64 Posted - 6 days ago

$ESPR $LPTX $LXRX ESPR is absolutely not clinical stage with this label expansion they now have a BILLION dollar drug for sale !

User Image TraderMark71 Posted - 1 week ago

$LPTX $ESPR $LXRX These are mainly clinical stage biopharmaceutical companies. They are a gamble to invest in, which I do, but in small quantities. The hope is that they will be acquired or skyrocket in SP. The chances are slim but worth the gamble if diversified properly. I'm tired of seeing all of the whining because you all invested or expected too much of them. Some pay off but most won't, get over it. Enough with your stats, expectations and views of management. If you don't like it, start your own company and see if you can manage it any better. Splits and offerings are also part of it. This is not a cheap segment, it takes money. I've made money and lost money on these and I have become numb to it. I am just tired of seeing all of the whiners and pumpers on these threads. Hope for the best and prepare for the worst. (IE: diversify) Don't be greedy.

User Image Slambucket Posted - 1 week ago

$LPTX Based on past events, I’d expect orphan/fast track filings for CrC and breakthrough for gastric. If successful, the PR announcing FDA designations. Just something to possibly watch for….

User Image Apr4609 Posted - 1 week ago

$LPTX Does Gilead have a pd-1 What would make leap a good buyout fit for them

User Image camouflage14 Posted - 1 week ago

$LPTX I believe when I looked up this companies address when their drug initially failed, they operate out of a shed and the CEO has a missing front tooth

User Image MurrayK Posted - 1 week ago

$LPTX this stock is making me blow through my blood pressure medication at an alarming rate. Maybe Doug should branch out into ACE inhibitor medications. He has created plenty of patients on this board ready for enrollment.

User Image TrimT Posted - 1 week ago

$LPTX 🥱 I wonder whose short positions probably don’t feel very comfortable right now. Margin calls are always enjoyable…

User Image LabPsycho Posted - 1 week ago

$LPTX Every time I think about buying this, just in time management hoses over its current investors once again to keep me on the sidelines.

User Image SuperCool5000 Posted - 1 week ago

$LPTX @Redboal

User Image RainbowTrump Posted - 1 week ago

$LPTX can’t ever catch a break

User Image Apr4609 Posted - 1 week ago

@Slambucket @Moneymoney_nomnomnom 1)Remember that leap is updating large pharma periodically so whenever the data strikes a fancy someone could act (could be sooner than a year) 2) leap will have Gilead board member seat with investment 3) leap will be able to fully show gastric and Crc and a decent data set from endometrial 4) maybe we get some Claudin data also by then

User Image BiodegradableShxt Posted - 1 week ago

$LPTX What the flying fug is happening to my beloved shitco.

User Image Walter100 Posted - 1 week ago

$LPTX May this and more come true!

User Image Adorno99 Posted - 1 week ago

$LPTX come on 7:00 a.m. I wants me some cheap shares at this price. But the mofos will probably raise the price right at 6:59!

Analyst Ratings
Baird Outperform Mar 19, 24
HC Wainwright & Co. Buy Mar 19, 24
Mizuho Buy Nov 20, 23
Raymond James Outperform Nov 14, 23
Baird Outperform Aug 15, 23
HC Wainwright & Co. Buy Aug 15, 23
Raymond James Outperform Jul 13, 23
Raymond James Outperform Jun 23, 23